Lixte biotech Holdings Inc Live Stock Price Today, Share Analysis and Chart

Name: Lixte Biotechnology Holdings Inc: Is Infosys Ltd. worth buying?
Item: Lixte Biotechnology Holdings Inc
Rating: 1.29050
Author: Trendlyne DVM scores

about

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used ...

3.72 -0.19 (-4.86%)

40.58% Fall from 52W High

175.1K

XNAS Volume

XNAS 30 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

2.0 / 100

Technically Neutral

49.6 / 100

No estimates available

Lixte biotech Holdings Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lixte biotech Holdings Inc Live Stock Price Today, Share Analysis and Chart

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used ...

40.58% Fall from 52W High

SWOT Analysis

Lixte biotech Holdings Inc Live Price Chart